Literature DB >> 30526407

Interleukin-37 Protects Stem Cell-Based Cartilage Formation in an Inflammatory Osteoarthritis-Like Microenvironment.

Ellen Wilhelmina van Geffen1, Arjan Petrus Maria van Caam1, Elly Louise Vitters1, Henk Maria van Beuningen1, Fons Adrianus van de Loo1, Peter Leonardus Everardus Maria van Lent1, Marije Ingrid Koenders1, Peter Mario van der Kraan1.   

Abstract

IMPACT STATEMENT: Catabolic factors present in a damaged joint inhibit chondrogenic differentiation of mesenchymal stem cells, thereby reducing the chance for successful cartilage formation. By improving stem cell-based cartilage repair with interleukin-37 (IL37), we might be able to inhibit the worsening progression of focal cartilage defects and prevent further development of joint diseases such as osteoarthritis. This will avoid chronic pain and impaired joint mobility for patients and reduce costs for society.

Entities:  

Keywords:  IL1β; IL37; cartilage formation; mesenchymal stem cells; osteoarthritis

Mesh:

Substances:

Year:  2019        PMID: 30526407     DOI: 10.1089/ten.TEA.2018.0267

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  2 in total

1.  Counteractive Effects of IL-33 and IL-37 on Inflammation in Osteoarthritis.

Authors:  Vikrant Rai; Matthew F Dilisio; Farial Samadi; Devendra K Agrawal
Journal:  Int J Environ Res Public Health       Date:  2022-05-07       Impact factor: 4.614

Review 2.  Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis.

Authors:  Xiao-Na Xiang; Si-Yi Zhu; Hong-Chen He; Xi Yu; Yang Xu; Cheng-Qi He
Journal:  Stem Cell Res Ther       Date:  2022-01-10       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.